Odyssey Health, Inc.: 10-Q filed 2015-12-22

Name: Odyssey Health, Inc.: 10-Q filed 2015-12-22
Creator: Odyssey Health, Inc.

What Odyssey Health, Inc. reported in its quarterly report filed 2015-12-22 (fiscal Q1 2016): 19 published measures, 40 facts as tagged in accession 0001019687-15-004599.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-12-22
Fiscal period: fiscal Q1 2016
Accession: 0001019687-15-004599 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Odyssey Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-10-31	5,793	USD
At 2015-07-31	5,350	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-10-31	189,088	USD
At 2015-07-31	163,651	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-10-31	-183,295	USD
At 2015-07-31	-158,301	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-10-31	5,793	USD
At 2015-07-31	5,350	USD
At 2014-10-31	45,930	USD
At 2014-07-31	45,980	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-08-01 to 2015-10-31	-24,994	USD	92
2014-08-01 to 2014-10-31	-43,479	USD	92

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2015-08-01 to 2015-10-31	0	USD	92
2014-08-01 to 2014-10-31	138,303	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-10-31	-330,795	USD
At 2015-07-31	-305,801	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2015-08-01 to 2015-10-31	114,750,000	shares	92
2014-08-01 to 2014-10-31	114,750,000	shares	92

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2015-08-01 to 2015-10-31	0	USD/shares	92
2014-08-01 to 2014-10-31	0	USD/shares	92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-08-01 to 2015-10-31	-24,683	USD	92
2014-08-01 to 2014-10-31	-40,085	USD	92

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-08-01 to 2015-10-31	311	USD	92
2014-08-01 to 2014-10-31	3,394	USD	92

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-10-31	67,861	USD
At 2015-07-31	65,735	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2015-08-01 to 2015-10-31	0	USD	92
2014-08-01 to 2014-10-31	14,214	USD	92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-10-31	114,750,000	shares
At 2015-07-31	114,750,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2015-10-31	32,750	USD
At 2015-07-31	32,750	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2015-10-31	115,778	USD
At 2014-10-31	66,004	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-08-01 to 2015-10-31	24,683	USD	92
2014-08-01 to 2014-10-31	54,299	USD	92

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-08-01 to 2015-10-31	0	USD	92
2014-08-01 to 2014-10-31	16,920	USD	92

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2015-08-01 to 2015-10-31	2,126	USD	92
2014-08-01 to 2014-10-31	35,939	USD	92

Inspect the source

Entity: Odyssey Health, Inc. / CIK 0001626644
Captured: 2026-09-19T11:19:48.570Z
SEC response SHA-256: 1be33e1ca79fd1e1d5399b519a2ef141b4c1191380216b92c135e07a22902f7b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001626644.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))